87 related articles for article (PubMed ID: 18365400)
1. Targeting B cells and antibody in transplantation.
Clatworthy MR
Am J Transplant; 2011 Jul; 11(7):1359-67. PubMed ID: 21668625
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal anti-CD20 antibodies: mechanisms of action and monitoring of biological effects.
Renaudineau Y; Devauchelle-Pensec V; Hanrotel C; Pers JO; Saraux A; Youinou P
Joint Bone Spine; 2009 Oct; 76(5):458-63. PubMed ID: 19640767
[TBL] [Abstract][Full Text] [Related]
3. Capillary blood as an alternative specimen for enumeration of percentages of lymphocyte subsets.
Srisala S; Pongsakul N; Sahakijpicharn T; Hongeng S; Chutipongtanate S; Apiwattanakul N
BMC Res Notes; 2019 Sep; 12(1):633. PubMed ID: 31554512
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Internal Quality Control Material for Lymphocyte Subset Analysis.
Roh EY; Shin S; Yoon JH; Oh S; Park KU; Lee N; Song EY
Ann Lab Med; 2016 Jul; 36(4):358-61. PubMed ID: 27139609
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.
St Clair EW; Levesque MC; Prak ET; Vivino FB; Alappatt CJ; Spychala ME; Wedgwood J; McNamara J; Moser Sivils KL; Fisher L; Cohen P;
Arthritis Rheum; 2013 Apr; 65(4):1097-106. PubMed ID: 23334994
[TBL] [Abstract][Full Text] [Related]
6. Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting.
Sekiguchi DR; Sutter JA; Rickels MR; Naji A; Liu C; Propert KJ; Rogers WT; Prak ET
J Immunol Methods; 2011 Jan; 363(2):233-44. PubMed ID: 20933515
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of rituximab in organ transplantation.
Becker YT; Samaniego-Picota M; Sollinger HW
Transpl Int; 2006 Aug; 19(8):621-8. PubMed ID: 16827678
[TBL] [Abstract][Full Text] [Related]
8. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
[TBL] [Abstract][Full Text] [Related]
9. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
10. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
Sutter JA; Kwan-Morley J; Dunham J; Du YZ; Kamoun M; Albert D; Eisenberg RA; Luning Prak ET
Clin Immunol; 2008 Mar; 126(3):282-90. PubMed ID: 18226586
[TBL] [Abstract][Full Text] [Related]
12. B cell monitoring of transplant patients treated with anti-CD20.
Abdallah KO; Prak ET
Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
